GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Dementia and Geriatric Cognitive Disorders, S. Karger AG, Vol. 26, No. 3 ( 2008), p. 257-260
    Abstract: 〈 i 〉 Background/Aims: 〈 /i 〉 Alzheimer’s disease patients commonly suffer from behavioural and psychological symptoms of dementia (BPSD); a genetic component to the development of BPSD has been demonstrated. Genetic risk factors for other psychiatric disorders have been implicated in BPSD; however, this is the first known investigation of the dopamine transporter 〈 i 〉 (DAT1) 〈 /i 〉 gene in BPSD. 〈 i 〉 Methods: 〈 /i 〉 Our large cohort of 395 patients with probable Alzheimer’s disease was dichotomised into whether they had ever suffered from a given symptom over the study period or not, based on longitudinal data using the BPSD (Neuropsychiatric Inventory). These measures were related to the 〈 i 〉 DAT1 〈 /i 〉 3′-untranslated region (UTR) variable number tandem repeat (VNTR) polymorphism. 〈 i 〉 Results: 〈 /i 〉 Potential associations were revealed between the 9-repeat allele and presence of irritability and between the 10-repeat allele and aberrant motor behaviour (AMB); however, these do not remain significant after correction for multiple testing. No associations were observed with delusions, hallucinations, depression, agitation/aggression or elation. 〈 i 〉 Conclusion: 〈 /i 〉 Our data suggest that the 〈 i 〉 DAT1 〈 /i 〉 3′-UTR VNTR could play a role in susceptibility to irritability and AMB. The findings presented here require replication in large well-characterised cohorts.
    Type of Medium: Online Resource
    ISSN: 1420-8008 , 1421-9824
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2008
    detail.hit.zdb_id: 1482186-2
    detail.hit.zdb_id: 1360843-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    S. Karger AG ; 2007
    In:  Dementia and Geriatric Cognitive Disorders Vol. 24, No. 3 ( 2007), p. 201-206
    In: Dementia and Geriatric Cognitive Disorders, S. Karger AG, Vol. 24, No. 3 ( 2007), p. 201-206
    Abstract: 〈 i 〉 Background/Aims: 〈 /i 〉 Alzheimer disease (AD) patients commonly suffer from behavioural and psychological symptoms of dementia (BPSD). A genetic component to BPSD development in AD has been demonstrated. This is an investigation of whether the linked polymorphic region and variable number tandem repeat variants of the serotonin transporter 〈 i 〉 (SERT) 〈 /i 〉 are associated with BPSD. 〈 i 〉 Methods: 〈 /i 〉 The longitudinal measures of BPSD of our large cohort of 367 AD patients were assessed by the Neuropsychiatric Inventory. Measures with good evidence of serotonergic involvement (delusions, hallucinations, depression, anxiety, agitation/aggression and irritability) were related to genotype and allele frequencies of the linked polymorphic region and variable number tandem repeat variants. 〈 i 〉 Results: 〈 /i 〉 Analysis revealed significant relationships between the linked polymorphic region variant long allele with irritability and the variable number tandem repeat 10-repeat allele with psychosis, but no associations were found with depression, anxiety or agitation/aggression. 〈 i 〉 Conclusion: 〈 /i 〉 Our data and review of previous studies suggest 〈 i 〉 SERT 〈 /i 〉 could play a minor role in development of psychosis and aggressive/irritable tendencies; however, further investigations are required in large, well-characterized cohorts.
    Type of Medium: Online Resource
    ISSN: 1420-8008 , 1421-9824
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2007
    detail.hit.zdb_id: 1482186-2
    detail.hit.zdb_id: 1360843-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Dementia and Geriatric Cognitive Disorders, S. Karger AG, Vol. 23, No. 1 ( 2007), p. 60-66
    Abstract: The age distribution of the & #917;4 allelic form of the apolipoprotein E gene 〈 i 〉 (APOE) 〈 /i 〉 was investigated in 630 patients with Alzheimer’s disease (AD) with onset age ranging from 35 to 90 years. Overall, mean age at onset in 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele bearers was significantly later than that in nonbearers. However, when stratified into early onset AD (EOAD) and late onset (LOAD) groups, mean age at onset in EOAD cases bearing 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele was later than that in those EOAD cases without & #917;4 allele, whereas in LOAD mean age at onset in cases bearing 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele was earlier than in those without & #917;4 allele. When analysed by decade, it was observed that 37% of the total number of 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele bearers, and 43% of total number of cases with 〈 i 〉 APOE 〈 /i 〉 & #917;4/ & #917;4 genotype fell into the 60–69 years age class. Hence, 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele frequency, at 0.44, was highest in the 60–69 years age class, progressively decreasing either side of this age group. 〈 i 〉 APOE 〈 /i 〉 & #917;4 allele therefore has its maximum impact between onset ages of between 60 and 70 years.
    Type of Medium: Online Resource
    ISSN: 1420-8008 , 1421-9824
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2007
    detail.hit.zdb_id: 1482186-2
    detail.hit.zdb_id: 1360843-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...